This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, D.-M. Articles by Uckun, F. M. Search for Related Content PubMed PubMed Citation Articles by Zhu, D.-M. Articles by Uckun, F. M.

Calpain Inhibitor II Induces Caspase-dependent Apoptosis in Human Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma Cells as Well as Some Solid Tumor Cells

Parker Hughes Cancer Center [D-M. Z.] and Departments of Immunology, Experimental Oncology [D-M. Z., F. M. U.], and Drug Discovery Program [F. M. U.], Wayne Hughes Institute, Roseville, Minnesota 55113

Calpain is a calcium-dependent cysteine protease that is implicated in calcium-dependent cell death, and calpain inhibitors are generally considered as inhibitors of apoptosis. To the contrary, in the present study, we found that calpain inhibitor II (CPI-2) triggers rapid apoptosis in acute lymphoblastic leukemia (ALL) and non-Hodgkin’s lymphoma (NHL) cells. All target cell lines were killed by CPI-2, including: ALL-1, a multidrug-resistant BCR-ABL fusion transcript-positive t(9;22) pro-B ALL cell line; RS4;11, a highly radiation-resistant MLL-AF4 fusion transcript-positive t(4;11) pre-pre B ALL cell line; RAMOS, a highly radiation-resistant and p53-deficient Burkitt’s lymphoma cell line; DAUDI, a Burkitt’s leukemia/lymphoma cell line; NALM-6, a pre-B ALL cell line; and JURKAT and MOLT-3, two T-lineage ALL/NHL cell lines. CPI-2-induced apoptosis in LYN-deficient and BTK-deficient subclones of the DT-40 lymphoma B cell line as effectively as it did in wild-type DT-40 cells. Thus, CPI-2-induced apoptosis is not dependent on the protein tyrosine kinases LYN or BTK. Notably, caspase inhibitor I effectively inhibited CPI-2-induced apoptosis, suggesting that the inhibition of a CPI-2-susceptible protease results in caspase activation, leading to apoptosis in ALL/NHL cells. Unlike the high calpain-expressing ALL/NHL cell lines, myeloid leukemia cell lines HL-60/AML, K562/CML, and U937/AMML, or solid tumor cell lines BT-20/breast cancer, PC-3/prostate cancer, U373/glioblastoma, and HeLa/epitheloid cancer, were not susceptible to the cytotoxicity of CPI-2. Taken together, our results identify calpain as a new molecular target for the treatment of ALL and NHL. CPI-2 and its analogues represent a promising new class of antileukemia/lymphoma agents that deserves further development.

This article has been cited by other articles:

				M. Niapour, Y. Yu, and S. A. Berger Regulation of Calpain Activity by c-Myc through Calpastatin and Promotion of Transformation in c-Myc-negative Cells by Calpastatin Suppression J. Biol. Chem., August 1, 2008; 283(31): 21371 - 21381. [Abstract] [Full Text] [PDF]

				A. Lakshmikuttyamma, P. Selvakumar, R. Kanthan, S. C. Kanthan, and R. K. Sharma Overexpression of m-Calpain in Human Colorectal Adenocarcinomas Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1604 - 1609. [Abstract] [Full Text] [PDF]

				M. Sedarous, E. Keramaris, M. O'Hare, E. Melloni, R. S. Slack, J. S. Elce, P. A. Greer, and D. S. Park Calpains Mediate p53 Activation and Neuronal Death Evoked by DNA Damage J. Biol. Chem., July 3, 2003; 278(28): 26031 - 26038. [Abstract] [Full Text] [PDF]

				R. W. Neumar, Y. A. Xu, H. Gada, R. P. Guttmann, and R. Siman Cross-talk between Calpain and Caspase Proteolytic Systems During Neuronal Apoptosis J. Biol. Chem., April 11, 2003; 278(16): 14162 - 14167. [Abstract] [Full Text] [PDF]